Publication | Open Access

Synthesis of novel 1,2,3-triazole based benzoxazolinones: Their TNF-α based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation

Molecular PharmacologyMedicinal ChemistryAntinociceptive ActivitiesDiversity Oriented SynthesisMedicinePharmacological AgentIn-vivo Anti-inflammatoryPharmacotherapyDrug DevelopmentPharmacologyPharmaceutical ChemistryUlcerogenic Risk EvaluationDrug Discovery